Somatostatin analogs: does pharmacology impact antitumor efficacy?Mounira Chalabi, Corinne Bousquet, Delphine Vezzosi et al.|Trends in Endocrinology and Metabolism|2014Cited by 97
Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor TherapyCorinne Bousquet, Stéphane Pyronnet, Charline Lasfargues et al.|The Journal of Clinical Endocrinology & Metabolism|2011Cited by 87
Impact de l’expression du récepteur de somatostatine sst2 sur la réponse au traitement des insulinomes par des analogues de somatostatineM. Vialon, Stéphane Pyronnet, Corinne Bousquet et al.|Annales d Endocrinologie|2016Cited by 0